Market Overview

UPDATE: Morgan Stanley Downgrades CIT Group to Equal-Weight on Fewer Catalysts Outstanding

Share:
Related CIT
Benzinga's Top Upgrades, Downgrades For February 5, 2018
Oppenheimer Serves Up 29 Top Stock Ideas For January
Hudson Executive Capital LP Buys Cardtronics PLC, Acorda Therapeutics Inc, FCB Financial ... (GuruFocus)

Morgan Stanley downgraded CIT Group (NYSE: CIT) from Overweight to Equal-weight and maintained a $46.00 price target.

Morgan Stanley said, "Risk-reward skew looks more balanced; we see fewer NT catalysts to drive CIT meaningfully higher. CIT shares are up 18% from lows post 3Q12 earnings as the company has achieved several key milestones to achieving their long-term targets, most importantly the elimination of more than $15B of high-cost debt and growing deposits to 31% of funding. Next catalysts for the stock include approval of CIT's capital plan, removal of the written agreement, and potential acquisitions (as indicated by mangement)."

CIT Group closed at $42.71 on Wednesday.

Latest Ratings for CIT

DateFirmActionFromTo
Feb 2018Credit SuisseMaintainsNeutralNeutral
Feb 2018Morgan StanleyMaintainsEqual-WeightEqual-Weight
Feb 2018BMO CapitalUpgradesUnderperformMarket Perform

View More Analyst Ratings for CIT
View the Latest Analyst Ratings

Posted-In: Morgan StanleyAnalyst Color Downgrades Analyst Ratings

 

Related Articles (CIT)

View Comments and Join the Discussion!